<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320849</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00103284</org_study_id>
    <nct_id>NCT04320849</nct_id>
  </id_info>
  <brief_title>Human Use Condition Study- Evaluation of Implanted Leads in Humans</brief_title>
  <acronym>HUCS</acronym>
  <official_title>Human Use Condition Study-Fluoroscopic Evaluation of 3D Curvature of Implanted Right Ventricular Leads in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate different types of leads (wires) that are connected&#xD;
      to your pacemaker (an implanted device which assists your heart function) to understand how&#xD;
      the shape and motion of your previously implanted lead changes in the body.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate different types of leads (wires) that are connected&#xD;
      to the pacemaker (an implanted device which assists enrolled subject's heart function) to&#xD;
      understand how the shape and motion of the previously implanted lead changes in the body.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">January 21, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 21, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In vivo cyclic curvature and mean curvature of pacing and defibrillation leads in the extravenous region will be determined during specified arm movements.</measure>
    <time_frame>Approximately 1 month</time_frame>
    <description>Measure dynamic in vivo curvature of RV pacing and defibrillator leads in the extravenous and intracardiac anatomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In vivo cyclic curvature and mean curvature of pacing and defibrillation leads in the intracardiac region will be determined during two or more cardiac cycles.</measure>
    <time_frame>Approximately 1 month</time_frame>
    <description>Measure the relationship between lead bending stiffness and in vivo curvature</description>
  </primary_outcome>
  <primary_outcome>
    <measure>In vivo cyclic curvature and mean curvature of pacing and defibrillation leads in the connector region will be determined during specified arm movements.</measure>
    <time_frame>Approximately 1 month</time_frame>
    <description>Assess the relationship between subject and implant variables and lead curvature</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Pacemaker Malfunction</condition>
  <arm_group>
    <arm_group_label>Patients with Biotronik Leads</arm_group_label>
    <description>Patients with these models: LSiello S, Solia S&#xD;
Description: Active Fixation Leads</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Boston Scientific Leads</arm_group_label>
    <description>Patients with these models: 4452, 4453, 4456, 4457&#xD;
Description: FINELINE II/FINELINE II Sterox Passive Fixation (polyurethane)&#xD;
Boston Scientific 4463, 4464, 4465, 4469, 4470, 4471 FINELINE II/FINELINE II Sterox EZ Positive Fixation (polyurethane)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Abbott Leads</arm_group_label>
    <description>Patients with these models: LDA 210Q&#xD;
Description: Optisure Single Coil Defibrillation Lead</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Medtronic Leads</arm_group_label>
    <description>Patients with these model: 6935M&#xD;
Description:Quattro Secure Single Coil Defibrillation Lead</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study will enroll at least 160 subjects with one of four different market-released lead&#xD;
        families identified in the tables below.&#xD;
&#xD;
        The leads are from all four CIED manufacturers participating in this protocol. A minimum of&#xD;
        40 leads from each manufacturer's lead family will be required.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with RV leads included in the scope of this study whose system has been implanted&#xD;
        for at least 3 calendar months Patients at least 18 years of age and capable of providing&#xD;
        informed consent Patients who can physically perform range of arm motion and breath-holding&#xD;
        described in the imaging protocol Patients who are willing and able to comply with&#xD;
        instruction related to the imaging protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Planned lead modification Patients with abandoned leads (includes: RV/RA/LV) Patients&#xD;
        undergoing second or subsequent pulse generator change Patient has permanent atrial&#xD;
        arrhythmias Limited life expectancy or medical condition that would not allow completion of&#xD;
        the study Patient is known to be pregnant or breastfeeding at time of consent Limited range&#xD;
        of mobility of the implant location arm Patient is unable to climb on and off an&#xD;
        examination table unassisted Patients deemed hemodynamically unstable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Piccini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MercyOne Iowa Heart Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>United Heart and Vascular Clinic</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Clinic</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

